New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Emerging Tests-dtet
Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
When Is Genome Sequencing Advisable?
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
AI and Wearable Devices Offer Promise as an Early COVID-19 ID Method
While still in its infancy, recent research shows the combination of AI and wearables can accurately detect early SARS-CoV-2 infection.
Blood-Based Alzheimer’s Tests Have Officially Arrived
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
Does Race Affect Interpretation of Alzheimer’s Blood Test Results?
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
Global DTC Genetic Testing Market to Top $1.9B by 2026
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Could CRISPR-Based Options Be the Next Generation of COVID-19 Diagnostics?
...
Already a member? Log in here
Blood-Based Test Uses Lipid Profiles to Detect Early-Stage Lung Cancer
Research team creates a promising new mass spectrometry-based blood lipid test.
Beyond the Pap Smear: New Methods to Improve Cytological Screening
...
Already a member? Log in here
One-Step HCV RNA Tests Help Encourage Hepatitis C Screening
...
Already a member? Log in here
New Blood Test Enables Early Cancer Detection in “Low-Risk, but Not No-Risk” Patients
...
Already a member? Log in here
Technological Advances Expected to Drive Huge Growth in Diabetes Testing
...
Already a member? Log in here
